Search alternatives:
significantly improve » significantly improved (Expand Search)
improve decrease » improve disease (Expand Search), improved urease (Expand Search), improves disease (Expand Search)
sizes decrease » scores decreased (Expand Search), rivers decreased (Expand Search)
i.e decrease » we decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
Showing 1 - 20 results of 6,792 for search '(( significantly improve decrease ) OR ( significant ((i.e decrease) OR (sizes decrease)) ))', query time: 0.53s Refine Results
  1. 1
    Soil partice-size distribution.

    Soil partice-size distribution. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    <i>e-lgp</i> curve of improved red clay.

    <i>e-lgp</i> curve of improved red clay. by Quan Shen (37564)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.

    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

    Published 2025
    “…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”
    Save to List
    Saved in:
  4. 4
    Comparison of the Non-healed but Improved DUs Based on Initial Wound Area Size in 2022 vs. 2023.

    Comparison of the Non-healed but Improved DUs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Comparison of the Non-healed but Improved PIs Based on Initial Wound Area Size in 2022 vs. 2023.

    Comparison of the Non-healed but Improved PIs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    JP4-039 decreases mitochondrial ROS in human coronary artery endothelial cells <i>in vitro.</i>

    JP4-039 decreases mitochondrial ROS in human coronary artery endothelial cells <i>in vitro.</i> by Rayane Brinck Teixeira (6676529)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Enrichment analysis of genes from the significant MS module.

    Enrichment analysis of genes from the significant MS module. by Lai Jiang (2401513)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Group-based descriptive statistics and effect sizes.

    Group-based descriptive statistics and effect sizes. by Murat Tutar (22250461)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Transition probabilities and class sizes for three-step LTA model (N = 432).

    Transition probabilities and class sizes for three-step LTA model (N = 432). by Carolin Oetzmann (11397968)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Particle size distribution curve.

    Particle size distribution curve. by Quan Shen (37564)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Based on our time series data(first from the left), the visualizations of linear residual predictions under different decimation rates (next three) show that as the decimation rate decreases, the range of residual variations also becomes smaller.

    Based on our time series data(first from the left), the visualizations of linear residual predictions under different decimation rates (next three) show that as the decimation rate... by Hua Huo (1818133)

    Published 2025
    Save to List
    Saved in:
  12. 12
    Brain regions with significantly decreased activations for the Raven task are shown in blue.

    Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

    Published 2025
    Save to List
    Saved in:
  13. 13
    Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells.

    Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

    Published 2024
    Save to List
    Saved in:
  14. 14
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  15. 15
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 16
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 17
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 18
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  19. 19
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  20. 20
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:

Search Tools: